TP53 and neoplasm: This showed two groups that had very different outcomes, those patients with high t2/t1 tumor levels and TP53 mutation had frequent metastases, but a group of 28 patients (representing ~1/3 of the cohort) with low t2/t1 tumor levels and no TP53 mutation where only one patient developed metastases.